- By Simon Harker
- In
- Posted Wednesday February 20, 2019
Dispensing practices affected by crackdown on fake medicines
The issue of counterfeit medicines is a growing concern, and the Falsified Medicines Directive (FMD) has been put in place to help solve the problem. As of February 9, GP practices are expected to comply with an initiative described as ‘the safest medicines system in the world’.
As part of the directive, medicine manufacturers have added unique 2D data barcodes and tamper-proof security seals to the packaging of their products.
Affected primary care organisations need to put the infrastructure and processes in place to be able to scan the medicines and ensure they are legitimate. When medicines are supplied to patients, the unique identifier is ‘decommissioned’ by scanning it into the FMD system.
The BMA advises that even non-dispensing practices that prescribe and administer vaccines should have the infrastructure and processes in place to decommission medicines.
The General Practitioners Committee of the BMA stated concerns that “the authentication system will result in burdensome bureaucracy for pharmacists, practices and dispensing doctors and that it will not fit in with current pharmacy/dispensary IT systems”.
There is a twist however – because this is an EU directive, the UK may no longer have to comply with it in the case of a ‘No Deal’ Brexit, adding an extra layer of uncertainty to the rollout of the new system.
Has your practice had to take steps to comply with the FMD, and have you experienced any issues with the initiative? Let us know your thoughts in the comment section below.
First Practice Management members can head to the Policies and Procedures Library now to download our new Falsified Medicines Directive (FMD) Policy.
Comments
Nigel Kenward 20/02/2019
This is an odd situation at present as we have only 2 drug packages in our dispensary that have the 2D barcodes on them. Some of the lines have had package re-design which seems to allow space for these but not yet. Strange that practices have to comply with every change in CQC, contract, NHSE, Dept Health, HMRC, HSE etc etc etc on time but 9th Feb has passed and FMD is still not active. I wonder of supply issues and Brexit have side-tracked the pharmaceutical powers that be?
Leave a Comment
Related Posts
A Letter to Myself as a New Practice Manager
1 March 2017
Practices' locum pay arrangements under the IR35 spotlight
15 October 2018
CQC has ‘improved the quality of care’ in general practice
23 October 2018
Pension scheme tax allowance changes a relief for GPs
5 November 2018
Secret Diary of a PM – A GDPR Dilemma
21 November 2018
Categories
Popular Blog Tags
Post Archive
Trending
Upcoming Events
Jobs
What others are viewing now
Latest Forum Posts
First Practice Management (FPM) is the UK's premier resource for GP practice managers. We help practice managers to get their practice compliant with regulation and to stay compliant.
Useful Links
Contact Us
Indigo House, Sussex Avenue,
Leeds, LS10 2LF
Phone: 0333 240 4010
Email: mail@firstpracticemanagement.co.uk
2019 © All Rights Reserved. Privacy Policy | Terms of Service